The influence of the promotional prac-tices of pharmaceutical manufacturers on the
prescribing behaviour of physicians has long been recognized. Since the early 1980s …

Drug promotions and marketing initiatives by pharmaceutical companies have a substantial
impact on the prescribing pattern of physicians in terms of non rational prescribing …

Promotion is ubiquitous in clinical practice. Industry funds most medical research and much
continuing medical education. Many clinical experts are paid by the industry to be 'key …

Abstract The CMA Board of Directors has responded to growing physician concern about
prescription-drug advertising aimed at patients by issuing a position paper that calls for strict …

Report calls for end of drug promotion to doctors Report calls for end of drug promotion to doctors
Abstract Product promotion among doctors by drug companies and medical device …

Background European Union law prohibits companies from marketing drugs off-label. In the
United Kingdom—as in some other European countries, but unlike the United States …

Most countries ban the advertising of prescription medication directly to consumers, yet
allow drug companies to promote drugs to doctors intensively. Such a differential treatment …

During the last year, many papers in scientific journals have commented on the possible
removal of the ban on directto-consumer advertising (DTCA) of prescription drugs by the …

James cave, Editor-in-Chief The Downland Practice, Berkshire, UK correspondence to
jcave@ bmj. com in the uK, the promotion and advertising of prescription-only medicines …

Many factors contribute to the inappropriate use of medicines, including not only a lack of
information but also inaccurate and misleading promotional information. This review …